3 13 46. Meylaerts LJ, Wijnen L, Grieten M, Palmers Y, Ombelet W, Vandersteen M. Junctional zone thickness in young nulliparous women according to menstrual cycle and hormonal contraception use. Reprod Biomed Online. 2017; 47. Novellas S, Chassang M, Delotte J, Toullalan O, Chevallier A, Bouaziz J, et al. MRI characteristics of the uterine junctional zone: From normal to the diagnosis of adenomyosis. American Journal of Roentgenology. 2011. 48. Kido A, Togashi K, Koyama T, Yamaoka T, Fujiwara T, Fujii S. Diffusely enlarged uterus: evaluation with MR imaging. Radiographics [Internet]. 2003 Nov;23(6):1423–39. Available from: https://www.ncbi.nlm.nih.gov/pubmed/14615554 49. Gong C, Yang B, Shi Y, Liu Z, Wan L, Zhang H, et al. Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: A retrospective study. Int J Hyperth. 2016; 50. Mochimaru A, Aoki S, Oba MS, Kurasawa K, Takahashi T, Hirahara F. Adverse pregnancy outcomes associated with adenomyosis with uterine enlargement. J Obstet Gynaecol Res. 2015; 51. Kissler S, Zangos S, Kohl J, Wiegratz I, Rody A, Gätje R, et al. Duration of dysmenorrhoea and extent of adenomyosis visualised by magnetic resonance imaging. Eur J Obstet Gynecol Reprod Biol. 2008; 52. Keserci B, Duc NM. Magnetic resonance imaging features influencing high-intensity focused ultrasound ablation of adenomyosis with a nonperfused volume ratio of ≥90% as a measure of clinical treatment success: retrospective multivariate analysis. Int J Hyperth. 2018; 53. Froeling V, Scheurig-Muenkler C, Hamm B, Kroencke TJ. Uterine artery embolization to treat uterine adenomyosis with or without uterine leiomyomata: Results of symptom control and health-related quality of life 40 months after treatment. Cardiovasc Intervent Radiol. 2012; 54. Dashottar S, Singh AK, Debnath J, Muralidharan CG, Singh RK, Kumar S. Comparative analysis of changes in MR imaging of pre and post intrauterine progesterone implants in adenomyosis cases. Med journal, Armed Forces India [Internet]. 2015 Apr;71(2):145–51. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25859077 55. Marnach ML, Laughlin-Tommaso SK. Evaluation and Management of Abnormal Uterine Bleeding. Mayo Clin Proc [Internet]. 2019;94(2):326–35. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30711128 56. Pontis A, D’Alterio MN, Pirarba S, de Angelis C, Tinelli R, Angioni S. Adenomyosis: a systematic review of medical treatment. Gynecol Endocrinol [Internet]. 2016 Sep;32(9):696–700. Available from:
RkJQdWJsaXNoZXIy MTk4NDMw